Castrated Men Exhibit Bone Loss: Effect of Calcitonin Treatment on Biochemical Indices of Bone Remodeling

Journal of Clinical Endocrinology and Metabolism

Volumn 69, Issue 3, 1989, Pages 523-527

  štěpán, Jan J ^a,b   Lachman, Miloš ^a,b   Zvěřina, Jan ^a,b   Pacovsky, Vladimír ^a,b   Baylink, David J ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE ISOENZYME; BONE MINERAL; CALCITONIN; SALCATONIN; TESTOSTERONE;

ADULT; BONE ATROPHY; CASTRATION; CLINICAL ARTICLE; HUMAN; HYDROXYPROLINE URINE LEVEL; INTRANASAL DRUG ADMINISTRATION; MALE; MALE HYPOGONADISM; OSTEOCALCIN BLOOD LEVEL; PRIORITY JOURNAL;

ADULT; BONE AND BONES; BONE DEVELOPMENT; BONE DISEASES, METABOLIC; CALCITONIN; CALCIUM-BINDING PROTEINS; CREATININE; HUMAN; HYDROXYPROLINE; MALE; MINERALS; ORCHIECTOMY; OSTEOCALCIN; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0024424879     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-69-3-523     Document Type: Article

References (29)

1. Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton III LJ. Differential changes in bone mineral density of the appendicular and axial skeleton with aging. J Clin Invest. 1981;67:328-35.
2. Melton III LJ, O’Fallon WM, Riggs BL. Secular trends in the incidence of hip fractures. Calcif Tissue Int. 1987;41:57-64.
3. Baker WG, Burger HG, de Kretser DM, et al. Changes in the pituitary-testicular system with age. Clin Endocrinol (Oxf). 1976;5:349-72.
4. Francis RM, Peacock M, Aaron JE, et al. Osteoporosis in hypogon-adal men: role of decreased plasma 1, 25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone. 1986;7:261-8.
5. Seeman E, Melton III LJ, O’Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med. 1983;75:977-83.
6. Greenspan SL, Neer RM, Ridgway EC, Klibanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med. 1986;104:777-82.
7. Jackson JA, Kleerekoper M, Parfitt AM, Rao DS, Villanueva AR, Frame B. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab. 1987;65:53-8.
8. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF. Osteoporosis in men with idiopathic hypogona-dotrophic hypogonadism. Ann Intern Med. 1987;106:354-61.
9. Meier DE, Orwoll ES. Marked decline in male vertebral bone mineral content with age: association with free testosterone levels [Abstract]. Clin Res. 1984;32:704A.
10. Foresta C, Ruzza G, Mioni R, Guarnieri G, Grimaldo R, Meneghello A, Mastrogiacomo I. Osteoporosis and decline of gonadal function in the elderly male. Horm Res. 1984;19:18-22.
11. Wink CS, Felts WJL. Effect of castration on the bone structure of male rats: a model of osteoporosis. Calcif Tissue Int. 1980;32:77-82.
12. Verhas M, Schoultens A, L’hermite-Baleriaux M, Dourov N, Ver-schaeren A, Mone M, Heilporn A. The effect of orchiectomy on bone metabolism in aging rats. Calcif Tissue Int. 1986;39:74-7.
13. Stepan JJ, Silinkovä-Malkovä E, Havränck T, et al. Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism. Clin Chim Acta. 1983;133:189-200.
14. Stepan JJ, Volek V, Kolär J. A modified inactivation-inhibition method for determining of the serum activity of alkaline phosphatase isoenzymes. Clin Chim. Acta. 1976;69:1-9.
15. Dubovsky J, Hrba J, Pacovsky V. Acute effects of calcium infusion of hydroxyproline. Clin Chim Acta. 1967;17:107-110.
16. Stepan JJ, Pospichal J, Presl J, Pacovsky V. Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. Bone. 1987;8:279-84.
17. Komm BS, Terpening CM, Benz DJ, et al. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science. 1988;241:81-4.
18. Eriksen EF, Colvard DS, Berg NG, et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 1988;241:84-6.
19. Colvard DS, Eriksen EF, Keeting PE, et al. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natal Acad Sei USA. 1989;86:854-57.
20. Ivey JL, Baylink DJ. Postmenopausal osteoporosis: proposed roles of defective coupling and estrogen deficiency. Metab Bone Dis Rel Res. 1981;3:3-7.
21. Gray TR, Mohan S, Linkhart TA, Williams ME, Baylink DJ. Estradiol may mediate its effects on bone cells by signaling the elaboration of growth factor [Abstract]. J Bone Mineral Res. 1988;3:S207.
22. Chenu C, Pfeilschifter J, Mundy GR, Roodman GD. Transforming growth factor ß inhibits formation of osteoclast-like cells in longterm human marrow cultures. Proc Natl Acad Sei USA. 1988;85:5683-7.
23. 3H] tetracycline excretion from prelabeled mice. J Bone Mineral Res. 1988;3:621-7.
24. Axelrod DW, Lachman DB, Judge D, Mallette LE, Gagel RF. Resorptive hypercalciuria and increased interleukin 1 in a young male with hypogonadism and osteoporosis: reversal with androgen treatment [Abstract]. Clin Res. 1989;37:21A.
25. Pacifici R, Rifas L, Vered I, et al. Interleukin-1 secretion from human blood monocytes in normal and osteoporotic women: effect of menopause and estrogen/progesterone treatment [Abstract]. J Bone Mineral Res. 1988;3:S204.
26. Foresta C, Busnardo B, Ruzza G, Zanetta G, Mioni R. Lower calcitonin levels in young hypogonadic men with osteoporosis. Horm Metab Res. 1983;15:206-7.
27. Ogata E, Shimazawa E, Suzuki H, Yoshitoshi Y, Asano H, Ando H. Androgens and enhancement of hypocalcemic response to thy-rocalcitonin in rats. Endocrinology 1970;87:421-6.
28. McDermott MT, Kidd GS. The role of calcitonin in the development and treatment of osteoporosis. Endocr. Rev. 1987;8:377-90.
29. Liu CC, Rader JI, Gruber H, Baylink DJ. Acute reduction in osteoclast number during bone repletion. Metab Bone Dis Rel Res. 1982;4:201-8.